Indus Gene Expressions Limited - Company Profile

It is a life sciences public limited company based in Chilamathur Mandal, Andhra Pradesh, India, established in 2007.

2007 Chilamathur Mandal, Andhra Pradesh, India Active

Last Updated: December 17, 2025

About Indus Gene Expressions Limited

Indus Gene Expressions Limited, a active public limited company, was established on 09 February 2007 in Chilamathur Mandal, Andhra Pradesh, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U24231AP2007PLC113311. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹100.00 Cr and a paid-up capital of ₹92.83 Cr.

Formerly known as Indus Gene Expressions Private Limited, Sri Balaji Biopharmaceuticals India Private Limited. It upholds a compliant status. Employing 29 professional, Its leadership includes Usharani Reddy C (Cfo), Channa Reddy C (Director), Meka Sudhakara Reddy (Additional Director). Past directors included Usharani Reddy C, Vemula Nilima, Mallikarjuna Reddy Beedupalli. It holds ₹32.63 Cr open charges and ₹30.40 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 6-312 Kodur Village, Kanisettipalli Post, Chilamathur Mandal, Andhra Pradesh, 515341.

Company Details

CIN/LLPIN
U24231AP2007PLC113311
Registration Number
113311
Incorporation Date
09 February 2007
Authorized Capital
₹100.00 Cr
Paid-Up Capital
₹92.83 Cr
ROC Code
Roc Vijayawada
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 100.00 Cr as on 17-12-2025
Paid Up Capital ₹ 92.83 Cr as on 17-12-2025
Company Age 19 Year, 7 Days
Last Filing with ROC 31 Mar 2023
Open Charges ₹ 32.63 Cr as on 17-12-2025
Satisfied Charges ₹ 30.40 Cr as on 17-12-2025
Revenue Growth **** 570.15% (FY 2023)
Profit Growth **** 142.29% (FY 2023)
Ebitda **** -156.62% (FY 2023)
Net Worth 26.98% (FY 2023)
Total Assets **** 18.00% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Indus Gene Expressions Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Indus Gene Expressions Limited?

Current Directors

Name	Designation	Appointment Date	Status
Usharani Reddy C	Cfo	03 Apr 2019	Current
Channa Reddy C	Director	06 Nov 2008	Current
Meka Sudhakara Reddy	Additional Director	06 May 2022	Current
Avula Sreenivasa Reddy	Additional Director	28 Oct 2019	Current
Muktha Puram Krishna	Additional Director	28 Sep 2024	Current
Abhinaya Chinthamani Reddy	Additional Director	15 Jan 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	30 Mar 2009	Past
Pramod Abcsdd	Additional Director	17 Dec 2024	Past
Pramod Abcsdd	Director	03 Apr 2019	Past
Pramod Abcsdd	Company Secretary	31 Jan 2025	Past
Pramod Abcsdd	Director	28 Oct 2019	Past
Pramod Abcsdd	Director	24 Feb 2011	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Indus Gene Expressions.

Indus Gene Expressions Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 570.15% increase. The company also saw a substantial improvement in profitability, with a 142.29% increase in profit. The company's net worth Soared by an impressive increase of 26.98%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

570.15%

*******

Revenue from Operations

*******

Total Assets

*******

18.00%

*******

Profit or Loss

*******

142.29%

*******

Net Worth

*******

26.98%

*******

EBITDA

*******

-156.62%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Indus Gene Expressions?

In 2023, Indus Gene Expressions had a promoter holding of 21.77% and a public holding of 78.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹326,300,000.00

Satisfied Charges

₹304,000,000.00

Charges Breakdown by Lending Institutions

Syndicate Bank : 29.00 Cr
Canara Bank : 3.63 Cr

Latest Charge Details

Date	Lender	Amount	Status
04 Sep 2020	Canara Bank	₹3.63 Cr	Open
21 Dec 2019	Syndicate Bank	₹29.00 Cr	Open
13 Oct 2014	Andhra Bank	₹30.40 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Indus Gene Expressions?

Unlock and access historical data on people associated with Indus Gene Expressions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Indus Gene Expressions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Gene Expressions's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Indus Gene Expressions

Recent Activity within the Organization

Director Appointment

Abhinaya Chinthamani Reddy was appointed as a Additional Director was appointed as a Additional Director on 15 Jan 2025 & has been associated with this company since 1 year 1 month . was recorded as a recent event.
15 Jan 2025
Director Appointment

The activity Muktha Puram Krishna was appointed as a Additional Director was appointed as a Additional Director on 28 Sep 2024 & has been associated with this company since 1 year 4 months . was completed.
28 Sep 2024
Annual General Meeting

Indus Gene Expressions Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
30 Sep 2023
Balance Sheet

The activity Indus Gene Expressions Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Vijayawada. was completed.
31 Mar 2023
Director Appointment

The activity Meka Sudhakara Reddy was appointed as a Additional Director was appointed as a Additional Director on 06 May 2022 & has been associated with this company since 3 years 9 months . was completed.
06 May 2022
Charges

Progress on A charge with Canara Bank amounted to Rs. 3.63 Cr with Charge ID 100369900 was registered on 04 Sep 2020. was documented.
04 Sep 2020

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Indus Gene Expressions Limited?

The CIN of Indus Gene Expressions Limited is U24231AP2007PLC113311.

Where is Indus Gene Expressions Limited headquartered?

Indus Gene Expressions Limited is headquartered at 6-312 Kodur Village, Kanisettipalli Post, Chilamathur Mandal, Andhra Pradesh, 515341.

When was Indus Gene Expressions Limited incorporated?

Indus Gene Expressions Limited was incorporated on 09 February 2007.

Who are the current directors of Indus Gene Expressions Limited?

The current directors of Indus Gene Expressions Limited are

What is the primary industry of Indus Gene Expressions Limited?

The primary industry of Indus Gene Expressions Limited is Professional, Scientific And Technical.

Is Indus Gene Expressions Limited a listed company?

Indus Gene Expressions Limited is unlisted.

What is the capital structure of Indus Gene Expressions Limited?

The authorized capital of Indus Gene Expressions Limited is ₹100.00 Cr, and the paid-up capital is ₹92.83 Cr.

What is the compliance status of Indus Gene Expressions Limited?

The compliance status of Indus Gene Expressions Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available